• Aduhelm's loss is a win for value-based drug pricing

    1 month ago - By MedCity News

    Value-based pricing could have shown us with more certainty the real level of effectiveness of Aduhelm. Maybe it is worth paying something for; and value-based contracts are the only way to figure that out.
    Read more ...